tiprankstipranks
Sanofi (SNYNF)
OTHER OTC:SNYNF
US Market
SNYNF
Sanofi
RESEARCH TOOLSreports
Want to see SNYNF full AI Analyst Report?

Sanofi (SNYNF) Stock News & Sentiment

389 Followers
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
Premium
Company Announcements
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
6d ago
REGN
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease
Premium
Company Announcements
Sanofi’s Lunsekimig Trial Update: New Momentum in Chronic Sinus Disease
23d ago
SNYNF
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch
Premium
Company Announcements
Sanofi Wraps Key Depakine Safety Study in Saudi Arabia: What Investors Should Watch
23d ago
SNYNF
Sanofi Advances Amlitelimab Program With Key Drug-Interaction Study Completion
Premium
Company Announcements
Sanofi Advances Amlitelimab Program With Key Drug-Interaction Study Completion
28d ago
SNYNF
Sanofi’s Lunsekimig Trial Reaches Key Milestone in Atopic Dermatitis Pipeline
Premium
Company Announcements
Sanofi’s Lunsekimig Trial Reaches Key Milestone in Atopic Dermatitis Pipeline
1M ago
SNYNF
SNYNF Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
SNYNF Earnings this Week: How Will it Perform?
1M ago
Balanced Risk-Reward Amid Promising Lunsekimig Data and Valuation Uncertainty Supports Hold Rating
Premium
Ratings
Balanced Risk-Reward Amid Promising Lunsekimig Data and Valuation Uncertainty Supports Hold Rating
1M ago
SNY
More SNYNF News >

SNYNF News on the Web

Trump Trade: Trump announces expansion of TrumpRx.gov
TipRanks News
Neutral
Sanofi Expands Alzheimer’s And Vaccine Efforts As Valuation Gap Widens
Simply Wall St
Neutral
Sanofi reports ElevAATe trial of efdoralprin alfa meets primary endpoint
TipRanks News
Bullish
Trump to announce ‘dramatic expansion’ of TrumpRx offerings, CNBC says
TipRanks News
Neutral
Regeneron price target lowered to $707 from $762 at RBC Capital
TipRanks News
Neutral
Will New Dupixent Data and AI Investment Shift Sanofi's (ENXTPA:SAN) Innovation-Led Growth Narrative?
Simply Wall St
Neutral
Davis to become acting director of CDER after Hoeg exit, Bloomberg says
TipRanks News
Neutral
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
TipRanks News
Bullish

News Score - Last 7 Days

Very Positive
SNYNF
Sector Average
Media Buzz
This Week8 articles
Weekly Average12.25 articles
News Sentiment
This Week100%
Sector Average77%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is SNYNF’s Media Buzz Sentiment?
8 articles about SNYNF were published this week. In an average week, 12.25 articles are published.
    What is SNYNF’s weekly average amount of articles?
    In an average week, 12.25 articles about SNYNF are published.
      What is SNYNF’s News Sentiment?
      100% of articles about SNYNF were positive this week, compared to its sector average of 77%.
        Healthcare Stocks that are Trending in the News
        GOSSGossamer Bio
        RLAYRelay Therapeutics
        IMVTImmunovant
        ROIVRoivant Sciences
        PROKProKidney
        Showing the stocks with the most bullish news sentiment over the past week